Study on the investigational drug SAN711, placebo-controlled, administered to healthy adults and elderly subjects at multiple ascending oral doses to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics of SAN711 and its interaction with food
This study is looking at a new potential medicine called SAN711. It's a very early-stage study, meaning it's the first time it’s being given to people. Researchers want to see if SAN711 is safe and how well people tolerate it. They also want to understand how the body processes the medicine and if eating food changes its effects. The study is specifically for healthy adults and older individuals. While the medicine is being tested in healthy people, it is ultimately hoped to help those with conditions like absence seizures (a type of epilepsy) and essential tremor (a common movement disorder). This research is a crucial step in developing new treatments.
At a glance
What is this study about?
This study is a very early step in developing a new medicine called SAN711. Think of it like a first test drive for a new car. The main goal at this stage is to make sure the medicine is safe for people to take and to understand how it behaves inside the body.
Researchers will give different doses of SAN711 to healthy volunteers, some of whom will be older adults. They'll closely check for any side effects and learn how the body takes in the medicine, breaks it down, and gets rid of it. They also want to see if eating food before or after taking the medicine changes how it works. Some people in the study will receive a placebo, which looks like the medicine but contains no active ingredients. This helps researchers fairly compare the effects of SAN711.
While this early study is done in healthy people, the new medicine is eventually hoped to help individuals with conditions like 'absence seizures,' which are brief moments of staring or unresponsiveness, and 'essential tremor,' which causes uncontrollable shaking primarily in the hands. By carefully studying SAN711 now, researchers can decide if it's safe and promising enough to move on to larger studies that test its effectiveness in people with these conditions. This work is essential for finding new ways to manage these health issues.
Key takeaways
- This is an early study testing a new medicine called SAN711.
- It's for healthy adults and older people, not those with existing conditions.
- The main goals are to check safety, how the body handles the medicine, and food effects.
- SAN711 is hoped to eventually help people with absence seizures or essential tremor.
- Participation involves taking the medicine and having regular health checks.
Who may be eligible?
This study is specifically looking for healthy adults and older individuals to take part. To be eligible, you must be at least 18 years old. There's no upper age limit, meaning older healthy people are also welcome to join.
The main requirement is that you are generally healthy. This means people with ongoing medical conditions or who are currently taking certain medications would likely not be able to participate. Both men and women can take part in this study.
If you're unsure whether you meet the health requirements, the study team will conduct thorough checks to make sure it's safe for you to participate.
- Are you 18 years old or older?
- Are you generally healthy with no ongoing medical conditions?
- Are you currently not taking any regular prescription medications?
- Are you able to attend study visits as required?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part, you would be given doses of the new medicine SAN711, or a placebo (a dummy pill with no medicine in it), by mouth. Researchers will watch you closely after you take the medicine to see how you react. This will involve regular check-ups, which might include blood tests, urine tests, and other physical examinations to monitor your health and how your body is handling the medicine.
You would also need to follow specific instructions about eating, as the study wants to see how food affects the medicine. The total length of your involvement in the study, including follow-up visits, would be explained to you in detail by the study team. You will have a clear schedule of visits and assessments if you join.
Potential risks and benefits
Locations (1)
- —Italy
Common questions
What is an 'investigational drug'?
It's a new medicine that researchers are testing for the first time in people. It hasn't been approved for general use yet.
What is a 'placebo'?
A placebo is a 'dummy' pill that looks just like the real medicine but contains no active ingredients. It helps compare the actual effects of the drug.
Why is this study only for healthy adults?
Early studies like this are done in healthy people first to safely learn how the medicine behaves in the body and identify potential side effects before testing it in patients with a specific condition.
What are 'absence seizures' and 'essential tremor'?
Absence seizures are brief moments of staring or unresponsiveness. Essential tremor causes involuntary shaking, usually in the hands.
Will I know if I'm getting the active drug or the placebo?
No, often in these studies, neither you nor the study team will know who is getting what until the study is over. This helps ensure unbiased results.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.